Working to strengthen its generics segment, Amneal Pharmaceuticals plans to launch a further eight new “high value” generics within the next year. “So far,” commented Chirag Patel, co-CEO, president and director of Amneal, “we have launched seven of our target of launching 15 new complex generic products by 2021.”
“Our goal of transitioning our product portfolio to complex generics is progressing nicely,” said co-CEO and director Chintu Patel, adding...







